Effect of Dapagliflozin in patients with type 2 daibetes mellitus
Phase of Trial: Phase IV
Latest Information Update: 12 Feb 2015
Price : $35 *
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 07 Feb 2015 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan record.
- 28 Oct 2014 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
- 27 Aug 2014 New trial record